fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Statin therapy cuts mortality by 25% among elderly

Written by | 24 Jul 2020

Article written by Bruce Sylvester Elderly patients without atherosclerotic cardiovascular disease (ASCVD) who initiated statin therapy have achieved a 25% reduction in the risk of early death..

Bimekizumab superior to Cosentyx in achieving complete psoriasis skin clearance. UCB

Written by | 24 Jul 2020

UCB announced positive results from the Phase IIIb BE RADIANT study, a direct comparison of the investigational IL-17A and IL-17F inhibitor, bimekizumab, to the IL-17A inhibitor, Cosentyx (secukinumab)… read more.

Breztri Aerosphere approved in the US for the maintenance treatment of COPD.- AstraZeneca

Written by | 24 Jul 2020

AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the US for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). The approval by the FDA… read more.

BioMarin files MAA at EMA for vosoritide to treat children with achondroplasia.

Written by | 24 Jul 2020

BioMarin Pharmaceutical Inc. announced that the company submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for vosoritide, an investigational, once daily injection analog of… read more.

G1 Therapeutics, Inc announces a license agreement for lerociclib to EQRx,

Written by | 24 Jul 2020

G1 Therapeutics, Inc. a clinical-stage oncology company, announced a license agreement for lerociclib to EQRx, a biopharmaceutical company focused on making innovative medicines at dramatically lower prices for… read more.

Clinical trials for seladelpar in NASH, PBC and PSC may resume- CymaBay Therapeutics

Written by | 24 Jul 2020

CymaBay Therapeutics announced that the FDA lifted clinical holds on seladelpar for all three Investigational New Drug (IND) Applications in Nonalcoholic Steatohepatitis (NASH), Primary Biliary Cholangitis (PBC) and… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.